If you are being treated for cholangiocarcinoma, on the occasion of your birthday, or an anniversary you particularly care about, you can organize a collective donation among your friends, colleagues and family in favor of the APIC to help research against this tumor. In this way, the people who love you would make a gift not only to you but to many other people who are fighting the same battle as you. We hope that APIC will soon be recognized as a third sector association (which until now were called non-profit organizations) and that donations to APIC can be tax deductible.
Donations in memory
If you have lost a loved one due to cholangiocarcinoma, instead of buying the flowers you can organize, together with friends, colleagues and relatives of your loved one, a collective donation to the APIC, to help research against this devastating cancer. We will provide you with information on where the sums collected will be destined and we will make available, on our site, a page, where you can publish a memory to honor those you have loved.
Become a Mentor
If you have had a personal experience of cholangiocarcinoma, as a patient or as a carer, you can become a mentor and provide support, empathy and understanding to people who have, have passed or have cared for, cholangiocarcinoma. The mentor is not asked for medical advice or recommendations, and in any case every aspect of the treatment should be discussed with a doctor.
We would like to develop a narrative medicine section, in which people who have had, or have, cholangiocarcinoma, or caregivers tell about their experience with the disease. This can help doctors and anyone caring for an individual with cholangiocarcinoma to better understand and assist. If you are interested go to this page .
Apic needs volunteers not only to assist patients but to inform the public, developing appropriate initiatives, to raise funds, to manage the Association itself.
Ask us your questions. We will get back to you as soon as possible. The head of this section is Professor Giovanni Brandi of the University of Bologna.
The study of genetic variations associated with cholangiocarcinoma involves two groups of people: those who have the disease and those who do not. Each participant is asked for a small blood sample from which to derive the DNA. The results are used to develop better prevention, medical control, diagnosis and treatment strategies.